Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals
The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened Tuesday at Phoenix Island in Jeju.
Search results for "new drug candidates"
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological approach relied on aggressive...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight
For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
![[USA-Harvard] The Anatomy of Innovation: Inside the World’s Premier Forge for Physician-Scientists](https://cdn.kormedi.com/wp-content/uploads/2025/10/kakaotalk-photo-2025-10-14-16-05-06.jpeg)
[USA-Harvard] The Anatomy of Innovation: Inside the World’s Premier Forge for Physician-Scientists
In a lab filled with robotic arms and the hum of precision engineering, a medical student in a white coat works...
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate
Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
ABL Bio Publishes Review Paper on Dual Antibodies in International Journal
ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody...